Work

A phase I pharmacodynamic and pharmacokinetic study of a Ras inhibitor, PRLX 93936, in patients with advanced solid tumors.

Year: 2010

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2010.28.15_suppl.e13042

Authors: R. K. Ramanathan, P. J. Rosen, A. J. Wagner, S. Sahasrabudhe, G. J. Weiss, P. Lee, M. Fuerst, P. Robbins, P. Litka, D. D. Von Hoff

Language: English

Topic: Protein Kinase Regulation and GTPase Signaling

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2249278248

Cites:

Cited by: 11

Related to: 10